PA-19-052 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Expired NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of Special Interest (NOSI): Cannabis, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults |
NOT-DA-20-014 |
NIDA
|
Apr 22, 2020 |
Sep 8, 2023
|
R01, R03, R21 |
Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) |
NOT-EB-20-007 |
NIBIB
|
Apr 10, 2020 |
Aug 29, 2020
|
R01, R21, R03 |
Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions |
NOT-CA-20-044 |
NCI
|
Apr 9, 2020 |
May 8, 2023
|
R03, R21, R01, P01 |
Notice of Special Interest: Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults |
NOT-MH-20-035 |
NIMH
|
Apr 1, 2020 |
May 8, 2023
|
R01, R21, R34, K01, K08, K23, R03, K99/R00, K24, R43/R44, R41/R42, K43, R25, R15, D43, F30, F31, F32, T32 |
Notice of Special Interest (NOSI): Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets |
NOT-MH-20-024 |
NIMH
|
Mar 30, 2020 |
May 8, 2023
|
R01, R21, R34, K01, K08, K23, R03, K99/R00, K24, R43/R44, R41/R42, K43, R25, R15, D43, F30, F31, F32, T32 |
Notice of Special Interest: Stigma or Other Social Determinants of Health (SDOH) in HIV Prevention and Treatment |
NOT-MH-20-020 |
NIMH
|
Mar 30, 2020 |
May 8, 2023
|
R01, R21, R34, K01, K08, K23, R03, K99/R00, K24, R43/R44, R41/R42, K43, R25, R15, D43, F30, F31, F32, T32 |
Notice of Special Interest (NOSI): Strengthening the HIV Care Continuum |
NOT-MH-20-023 |
NIMH
|
Mar 30, 2020 |
May 8, 2023
|
R01, R21, R34, K01, K08, K23, R03, K99/R00, K24, R43/R44, R41/R42, K43, R25, R15, D43, F30, F31, F32, T32 |
Notice of Special Interest (NOSI): Mental Health Comorbidities in HIV Prevention and Treatment |
NOT-MH-20-013 |
NIMH
|
Mar 30, 2020 |
May 8, 2023
|
R01, R21, R34, K01, K08, K23, R03, K99/R00, K24, R43/R44, R41/R42, K43, R25, R15, D43, F30, F31, F32, T32 |
Notice of Special Interest (NOSI): Strengthening the HIV Prevention Continuum |
NOT-MH-20-019 |
NIMH
|
Mar 27, 2020 |
May 8, 2023
|
R01, R21, R34, K01, K08, K23, R03, K99/R00, K24, R43/R44, R41/R42, K43, R25, R15, D43, F30, F31, F32, T32 |
RESCINDED - Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) |
NOT-AI-20-031 |
NIAID
|
Mar 27, 2020 |
Apr 5, 2021
|
R03, R21, 333, R01, R43/R44, R41/R42 |
Notice of Special Interest (NOSI): Exploring the Roles of Biomolecular Condensates (BMCs) in
Substance Use Disorder and/or HIV-related processes |
NOT-DA-20-018 |
NIDA
|
Mar 25, 2020 |
Sep 8, 2023
|
R01, R03, R21, 333 |
Notice of Special Interest (NOSI):Sleep and Substance Use Disorders |
NOT-DA-20-021 |
NIDA
|
Mar 25, 2020 |
Sep 8, 2023
|
R01, R03, R21, K99/R00, R61/R33 |
Notice of Special Interest (NOSI): Advancing Head and Neck Cancer Early Detection Research (AHEAD) |
NOT-CA-20-031 |
NCI NIDCR
|
Mar 10, 2020 |
Jan 8, 2022
|
R03, R21, R01 |
Notice of Special Interest (NOSI): Effects of Cannabis Use and Cannabinoids on the Developing Brain |
NOT-DA-20-039 |
NIDA
|
Mar 5, 2020 |
Sep 8, 2023
|
R01, R03, R21 |
Notice of Special Interest (NOSI): Going Global: Using Gene Network Analyses to Understand the Etiology of SUD |
NOT-DA-20-020 |
NIDA
|
Feb 26, 2020 |
Sep 8, 2023
|
R01, R03, R21, 333 |
Notice of Special Interest to Highlight Research Priorities for Risk Algorithms Applications in Healthcare Settings to Improve Suicide Prevention |
NOT-MH-20-031 |
NIMH
|
Feb 14, 2020 |
Jan 8, 2022
|
R34, R01, R21, R03 |
Notice of Special Interest (NOSI): Drug-drug interactions among substances of abuse, medications to treat HIV infection, and pharmacotherapies to treat substance use disorders |
NOT-DA-20-013 |
NIDA
|
Feb 6, 2020 |
May 8, 2022
|
R01, R03, R21 |
Notice of Special Interest (NOSI): Transcriptomic, epigenomic, regulatory RNA or functional genomic research in Substance Use Disorders |
NOT-DA-20-031 |
NIDA
|
Feb 6, 2020 |
Jan 8, 2023
|
R01, R03, R21, 333, R21/R33 |
Notice of Special Interest (NOSI): Preclinical and Clinical Studies of the Interactions of Opioids and Stimulants |
NOT-DA-20-007 |
NIDA
|
Jan 6, 2020 |
Jun 5, 2023
|
R03, R21, R01 |
Notice of Special Interest (NOSI): Modeling Social Contagion of Substance Use Epidemics |
NOT-DA-20-009 |
NIDA
|
Jan 2, 2020 |
Jan 8, 2023
|
R01, R03, R21 |
Notice of Special Interest (NOSI): Epidemiology of Drug Abuse |
NOT-DA-19-066 |
NIDA
|
Aug 29, 2019 |
Jan 8, 2022
|
R01, R21, R03, 333 |
Notice of Special Interest (NOSI): Public Health Research on Cannabis |
NOT-DA-19-065 |
NIDA
|
Aug 14, 2019 |
Jan 8, 2022
|
R01, R21, R03, 333 |
Notice of Special Interest (NOSI): The Application of Big Data Analytics to Drug Abuse Research |
NOT-DA-19-041 |
NIDA
|
Jul 12, 2019 |
Jan 8, 2022
|
R01, R21, R03 |
Notice of Special Interest (NOSI): Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R01, R21, R03) |
NOT-DA-19-037 |
NIDA
|
Jul 11, 2019 |
Sep 8, 2022
|
R01, R21, R03 |
Notice of Special Interest (NOSI): Research to Prevent Drug Use, Misuse and Addiction |
NOT-DA-19-048 |
NIDA
|
Jul 10, 2019 |
Jan 8, 2022
|
R01, R21, R03 |
Notice of Special Interest to Highlight High Priority Research Opportunities on Suicide Prevention Crisis Services |
NOT-MH-19-025 |
NIMH
|
Apr 23, 2019 |
Jan 8, 2022
|
R34, R01, R21, R03 |
Notice of Special Interest to Highlight High Priority Research Opportunities on Suicide Prevention Crisis Services |
NOT-MH-19-025 |
NIMH
|
Apr 23, 2019 |
Jan 8, 2022
|
R34, R01, R21, R03 |
Notice of Availability of Competitive Supplements/Revisions for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project (Competitive Supplement/Revision Clinical Trial Optional) |
NOT-OD-19-071 |
NIH
|
Feb 5, 2019 |
Mar 17, 2019
|
R01, R03, R21, U01 |
|